In short
Finerenone is an emerging drug being studied in clinical trials for its potential benefits in treating chronic kidney disease (CKD) and type 2 diabetes (T2D). This non-steroidal mineralocorticoid receptor antagonist has shown promise in slowing the progression of kidney disease and reducing cardiovascular risks in patients with these conditions. The ongoing trials aim to evaluate its efficacy, safety, and mechanisms of action across various patient populations.
At a glance
- Drug Name
- Finerenone (also known as BAY94-8862 or Kerendia)
- Drug Class
- Non-steroidal selective mineralocorticoid receptor antagonist (MRA)
- Primary Conditions Studied
- Chronic Kidney Disease (CKD) with Type 2 Diabetes (T2D)
- Other Conditions
- Primary Aldosteronism, Worsening Chronic Heart Failure
- Main Outcomes Measured
- Changes in UACR, eGFR, blood pressure, cardiovascular events, kidney disease progression
- Dosage
- 10-20 mg oral tablets, once daily (adjusted based on kidney function)
- Key Safety Monitoring
- Serum potassium levels, blood pressure, overall tolerability
- Potential Benefits
- Slowing CKD progression, reducing cardiovascular risks, improving vascular health
- Ongoing Research Focus
- Efficacy in various patient populations, long-term safety, mechanisms of action
What is Finerenone?
Finerenone is a new medication that belongs to a class of drugs called mineralocorticoid receptor antagonists (MRAs). It is also known by the brand name Kerendia. Finerenone is a non-steroidal MRA, which means it works differently from older medications in this class.
How Finerenone Works
Finerenone works by blocking a protein in the body called the mineralocorticoid receptor (MR). When this receptor is overactive, it can lead to problems like high blood pressure, organ damage, and worsening of heart failure. By blocking this receptor, Finerenone helps to reduce these harmful effects.
Conditions Treated by Finerenone
Finerenone is primarily used to treat two related conditions:
- Chronic Kidney Disease (CKD): This is a long-term condition where the kidneys gradually lose their ability to function properly.
- Type 2 Diabetes: This is a condition where the body doesn't use insulin properly, leading to high blood sugar levels.
Finerenone is particularly useful for patients who have both CKD and Type 2 diabetes, as these conditions often occur together and can worsen each other.
Effectiveness of Finerenone
Clinical trials have shown that Finerenone can be effective in:
- Slowing the progression of chronic kidney disease
- Reducing the risk of kidney failure
- Lowering the risk of cardiovascular events (such as heart attacks and strokes) in patients with CKD and Type 2 diabetes
- Reducing albuminuria, which is a sign of kidney damage
Dosage and Administration
Finerenone is typically taken as a tablet once daily. The starting dose may vary depending on the patient's kidney function:
- For patients with moderately reduced kidney function, the starting dose is usually 10 mg once daily.
- For patients with normal or mildly reduced kidney function, the starting dose may be 20 mg once daily.
The dose may be adjusted by your doctor based on your response to the medication and your blood test results.
Side Effects and Safety
Like all medications, Finerenone can cause side effects. The most common side effect is an increase in blood potassium levels (hyperkalemia). Other potential side effects include:
- Decreased kidney function
- Low blood pressure
- Dizziness
It's important to note that Finerenone appears to have fewer hormonal side effects (such as breast enlargement in men or menstrual irregularities) compared to older MRAs like spironolactone.
Ongoing Research
Researchers are currently conducting several studies to further understand the benefits and potential uses of Finerenone. Some areas of ongoing research include:
- Its effectiveness in treating primary aldosteronism, a condition that causes high blood pressure
- Its effects on vascular stiffness (hardening of the arteries) in patients with Type 2 diabetes and CKD
- Long-term safety and effectiveness in real-world settings
These ongoing studies will help doctors better understand how to use Finerenone effectively and safely in different patient groups.